|Day's Range||0.00 - 0.00|
|52 Week Range|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Categories: Yahoo Finance Get free summary analysis StemCells, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of StemCells, Inc. – BioTime, Inc., Geron Corporation, Repligen Corporation, Thermo Fisher Scientific Inc., NanoString Technologies, Inc., Bio-Techne Corporation, Cryo-Cell International, Inc. and Healthways, Inc. (BTX-US, GERN-US, RGEN-US, TMO-US, NSTG-US, ... Read more (Read more...)
It’s a relatively quiet day on Wall Street as all three indexes are close to break-even. Among the stocks gaining ground on Monday are Lantronix Inc (NASDAQ:LTRX), Rovi Corporation (NASDAQ:ROVI), Cheetah Mobile Inc (ADR) (NYSE:CMCM), StemCells Inc (NASDAQ:STEM), and Momo Inc (ADR) (NASDAQ:MOMO). Let’s find out why traders are buying each stock and use the latest 13F data to […]
StemCells (STEM) CEO Ian Massey and CFO Gregory Schiffman announced their resignations as the company announced its planned merger with Microbot Medical.